Navigation Links
CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients
Date:10/7/2008

esponding to initial therapy and continued in year 2 for remitters. Based on average wholesale prices for the treatments, estimate of treatment costs showed that CIMZIA provided more cost savings during induction and maintenance phases of treatment when compared to infliximab and adalimumab.

A cohort budget analysis, with uptakes of 60 percent, 30 percent and 10 percent in year 1 and 50 percent, 30 percent and 20 percent in year 2 for infliximab, adalimumab and CIMZIA, respectively, was performed for a healthcare plan of 5 million members with a CD prevalence of 162 per 100,000 and incidence rate of 9.6 per 100,000. Results showed that access to CIMZIA provided a savings of more than $1.5 million compared to a healthcare plan that did not include CIMZIA. The data suggest that based on standard regimens for each of the TNF alpha blockers for CD, CIMZIA may be less costly than the two biologics studied.

About WELCOME

The WELCOME study is a 539 patient Phase IIIb multicenter 26-Week trial Evaluating the clinical benefit and tolerability of certoLizumab pegol induCtiOn and Maintenance in patients suffering from Crohn's disease with prior loss of response or intolErance to infliximab. It consists of an open-label induction phase (400 mg of CIMZIA sub-cutaneously at Weeks 0, 2 and 4) and a double-blind maintenance period (400 mg of CIMZIA every 2 or 4 weeks from Week 6). The primary endpoint was defined as the rate of response (defined as a decrease in CDAI score less than or equal to 100 points from baseline) at Week 6. Remission was defined as a CDAI score of greater than or equal to 150 points. After the induction period, 62 percent of patients achieved response and 39 percent achieved remission. One-third of patients had responded to treatment by Week 2 (33 percent) and more than forty percent (44 percent) had responded by Week 4.

About the PRECiSE Clinical Trial Program

PRECiSE, one of the largest, most comprehensive development pro
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
2. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
3. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
4. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
5. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Raptor Pharmaceuticals Provides Update of Product Programs
8. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
9. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
10. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 Michael DeMarco (42) erinnert ... 14. Februar 2014 zugetragen hat. Seine Tochter Aly Demarco ... Video - http://youtu.be/5cVoMCe0uiE ... morgendliches Training zu machen", erzählt Michael DeMarco . ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem ...
(Date:11/21/2014)... , Nov. 20, 2014   Coqui RadioPharmaceuticals Corp. ... first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud ... INVAP to design its Medical Isotope Production ... Mo-99 is the parent isotope of Technetium-99, which is ... In 2012, Congress passed legislation making it a national ...
(Date:11/21/2014)... 2014   Wellcentive , the industry leader ... organizations, announced today being named one of the ... Award .  Sponsored by Intel, the world leader ... year, recognizes companies developing leading-edge technology and unique ... Wellcentive,s Mason Beard , ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
... Oct. 23 Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage ... will be presenting at the 8th Annual BIO Investor Forum 2009 ... 2009 at the Palace Hotel in San Francisco, California. Mr. ... research and development progress. A link to the live presentation ...
... , HOLLISTON, Mass., Oct. 23 Nyer Medical Group, Inc., ... wholly-owned subsidiary of Nyer which does business under the name ... Walgreen Eastern Co., Inc. for the sale of a substantial ... of a total of 12 neighborhood pharmacies which includes the ...
Cached Medicine Technology:Novavax to Present at 8th Annual BIO Investor Forum 2009 2Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 2Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 3Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 4
(Date:11/22/2014)... Domestic farmgate milk and dairy ... due to a fall in demand for ... amid the global financial crisis. However, these declines ... dairy manufacturers on the international scene. Strong growth ... growth, primarily due to supply constraints in some ...
(Date:11/22/2014)... The topic of B&D Rockeries’ latest publication is ... states that, “While they give off the appearance of simplicity ... creating this powerful look.” , One of the first and ... kind of block matches your home environment and best fulfills ... main options are concrete and stone blocks. But do not ...
(Date:11/22/2014)... has been a historical time for Angeldress.co.uk, an excellent wedding ... some renowned review websites. Recently, the company has added to ... of wonderful sexy wedding dresses to its website. At the ... to an 80% discount on any order over GBP 149. ... dress at Angeldress.co.uk, which has garnered a hard core of ...
(Date:11/22/2014)... 22, 2014 Recently, UWDress.com is gratified ... guest dresses . In addition, the company has also ... , As a leading online supplier of wedding dresses, ... outfits. The unusual best wedding guest gowns are provided ... amazing designs, this new selection is famous for high ...
(Date:11/22/2014)... 2014 The Sports Conflict Institute ... to its team of conflict resolution professionals. Baroff comes ... and referee. He has over 30 years experience as an ... “I'm very excited to connect with SCI and bring my ... to a program with a complete sports focus,” says Baroff. ...
Breaking Medicine News(10 mins):Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3
... typically fight bacteria, study finds , MONDAY, Oct. 1 ... air pollution, shuts down early immune responses in the ... to bacteria and other foreign invaders, research shows. , ... increased cardiovascular and pulmonary hospitalizations and deaths, but the ...
... Oct. 1 Sunnylife Global, Inc.,(Pink Sheets: SNYL) ... financial public relations services. At a time ... quality,healthcare management in China and build assisted-living housing ... to do so, with,approvals from China,s central government. ...
... HOFFMAN ESTATES, Ill., Oct. 1 In continuing support ... Serta is putting the,famous Counting Sheep back to work ... will honor two breast cancer survivors or,co-survivors with a ... a $5,000 donation to Komen for the Cure in ...
... Md., Oct. 1 The first lady of the,United ... her husband,s,governorship she intends to help improve the lives ... week Cecile deJongh saw a major piece of her ... Wednesday and Thursday, one on St. Croix,and the second ...
... 1 The Regulatory Affairs,Professionals Society (RAPS), ... products regulatory profession, announced at their annual,conference ... Affairs Professional,Development Framework: An Overview," a new ... of regulatory professionals. The white paper, ...
... Carry RESPeRATE ... Hypertension Treatment Device, NEW ... INCR), today announced that its RESPeRATE(R) hypertension,treatment device, clinically-proven ... launch into retail distribution in,Australia through its local marketing ...
Cached Medicine News:Health News:Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations 2Health News:Serta Brings Sweet Dreams and a Special Delivery to Deserving Women 2Health News:Serta Brings Sweet Dreams and a Special Delivery to Deserving Women 3Health News:First Lady of U.S. Virgin Islands Opens New CHADD Support Groups 2Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 2Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 3Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 3Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 4
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Sterile Isopropyl ... are primarily used as ... to administering injections. They ... meet AAMI/ANSI/ISO 11137 standards ...
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick....
Medicine Products: